The global genomics in cancer care market is forecasted to reach USD 39.94 Billion by 2027, according to a new report by Reports and Data. The genomics in cancer research market is observing high demand attributed to the rising incidence of cancer. Cancer has a significant impact on society in the U.S. and across the globe. It has been estimated that 1,735,350 new disease cases were diagnosed in the U.S., and 609,640 people suffered death from the disease. The number of new incidences of the disease is 439.2 per 100,000 men and women annually, and the number of cancer-related morbidities is 163.5 per 100,000 men and women annually. Moreover, it has been estimated that in 2017, 15,270 children and adolescents in the age range of 0-19 years were diagnosed with disease, out of which 1,790 suffered death owing to the disease. In the year 2017, an estimated USD 147.30 billion was spent on cancer care in the US.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3712
The report provides a panoramic view of the market and insights that will help formulate better business decisions. In addition to that, the study helps well-established companies and players gain a deeper understanding of the market and make informed decisions. The report also discusses in detail about the key factors influencing the market growth.
Key companies operating in the market include:
Agilent Technologies, Bio-Rad Laboratories, Qiagen, GE Healthcare, Roche Diagnostics, Abbott Laboratories, Illumina Inc., Cancer Genetics Inc., Sigma Aldrich, and Perkin Elmer, among others.
The report covers an extensive analysis of the key market players in the market along with their business overview, expansion plans, and strategies. The report also focuses on recent strategic alliances in the market including mergers and acquisitions, joint ventures, partnerships, agreements, corporate and government deals, product launches, and brand promotions, among others. The report aims to provide a better understanding of the market dynamics and the workings of the industry on a global level. To gain a deeper understanding of the industry, the global Genomics In Cancer Care market is further segmented on the basis of key geographical regions such as North America, Latin America, Europe, Asia-Pacific, and the Middle East & Africa. The report also offers a country-wise analysis to provide crucial insights into market size, market growth, market revenue growth, and economic growth in each region.
On basis of product types and application offered by the Genomics In Cancer Care industry, the market is segmented into:
Product Type Outlook (Revenue, USD Million; 2017-2027)
- Instruments
- Consumables
- Services
Technology Outlook (Revenue, USD Million; 2017-2027)
- PCR
- Genome Sequencing
- Nucleic Acid Extraction & Purification
- Microarray
- Others
Application Outlook (Revenue, USD Million; 2017-2027)
- Diagnostics
- Personalized Medicine
- Drug Discovery & Development
- Others
End-User Outlook (Revenue, USD Million; 2017-2027)
- Hospitals
- Research Institutes
- Others
The regional analysis covers:
- North America
- US.
- Canada
- Mexico
- Europe
- Germany
- UK.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- A.E.
- South Africa
- Rest of MEA
Benefits of Genomics In Cancer Care Market Report:
- Panoramic overview of the opportunities and risks in the Genomics In Cancer Care sector
- Study of recent innovations and developments in the industry
- Comprehensive study of the growth pattern of the Genomics In Cancer Care industry
- In-depth assessment of the competitive landscape of the key players of the Genomics In Cancer Care industry
- Analysis of the Genomics In Cancer Care market drivers, constraints, and opportunities
- Assessment of technological developments and latest trends of the industry
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/3712
Thank you for reading our report. For customization or further inquiry, please get in touch with us. Our team will ensure the report is tailored according to your requirements.
